Regular price: $7.95

Membership details Membership details
  • A 30-day trial plus your first audiobook, free.
  • 1 credit/month after trial – good for any book, any price.
  • Easy exchanges – swap any book you don’t love.
  • Keep your audiobooks, even if you cancel.
  • After your trial, Audible is just $14.95/month.
OR
In Cart

Publisher's Summary

Welcome to Forbes for May 9th, 2011, from Audible. This edition contains seven feature articles.

In the cover story, we'll tell you about... "Entrepreneurs: The 'Business' Gene" - is success passed along from one generation to the next?

Then, "Me and My Robot" - after decades of false starts, personal robots are finally going mainstream in the U.S.

We'll also tell you about: "Pfizer's Radical Surgery" - will new CEO Ian Read break up the world's largest drug company? Wall Street sure hopes so.

Next, "Fade to Black" - Peabody Energy is betting the whole show on coal - and on China, too.

Then, "Secret Agent" - public pensions are $660 billion in the hole. Investment middleman Glen Sergeon illustrates how millions more are being lost to dubious dealings.

That's followed by "The Best Schools for Your Real Estate Buck" - our second annual look at America's top districts again demolishes the idea that more money equals a better education.

And our final story: "The Retirement Spending Solution" - financial planner Bill Bengen defends his conclusion that retirees can spend 4.5% of their savings a year and not outlive their money.

Want to hear more Forbes?
Subscribe for one month or 12 months.
Get the latest issue.
Check out the complete archive.
© and (P) 2010 Forbes

What members say

Average Customer Ratings

Overall

  • 5 out of 5 stars
  • 5 Stars
    1
  • 4 Stars
    0
  • 3 Stars
    0
  • 2 Stars
    0
  • 1 Stars
    0

Performance

  • 0 out of 5 stars
  • 5 Stars
    0
  • 4 Stars
    0
  • 3 Stars
    0
  • 2 Stars
    0
  • 1 Stars
    0

Story

  • 0 out of 5 stars
  • 5 Stars
    0
  • 4 Stars
    0
  • 3 Stars
    0
  • 2 Stars
    0
  • 1 Stars
    0
No Reviews are Available